Publikationen in Zusammenarbeit mit Forschern von Hospital Municipal de Badalona (2)

2011

  1. Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: The AVACROSS study

    Oncologist, Vol. 16, Núm. 5, pp. 614-620

2010

  1. Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer

    Chemotherapy, Vol. 56, Núm. 2, pp. 142-146